Inventor · disambiguated record
Peter Sieger
Also filed as: SIEGER PETER
40 granted patents·37 pending applications·804 citations·filing 1999–2022
98Inventor score
Files withBOEHRINGER INGELHEIM INT35BOEHRINGER INGELHEIM PHARMA17LINZ GUENTER5SIEGER PETER5PFRENGLE WALDEMAR3
Top patents by PatentIndex Score
77 records- 0198US7220742B2Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicamentsBOEHRINGER INGELHEIM INT·Filed 2005·Granted May 22, 2007·32 cites·18 claims
- 0297US8106060B28-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticalsPFRENGLE WALDEMAR·Filed 2006·Granted Jan 31, 2012·67 cites·21 claims
- 0397US7439358B2Specific salt, anhydrous and crystalline form of a dihydropteridione derivativeBOEHRINGER INGELHEIM INT·Filed 2007·Granted Oct 21, 2008·50 cites·7 claims
- 0497US6908928B2Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2001·Granted Jun 21, 2005·93 cites·23 claims
- 0597US6777423B2Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Aug 17, 2004·128 cites·16 claims
- 0696US8865729B2Salt forms of a xanthine compoundSIEGER PETER·Filed 2009·Granted Oct 21, 2014·47 cites·10 claims
- 0795US9212183B2Salt forms of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-amino-piperidin-1-yl)-xanthineSIEGER PETER·Filed 2014·Granted Dec 15, 2015·33 cites·4 claims
- 0895US8637530B28-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticalsPFRENGLE WALDEMAR·Filed 2012·Granted Jan 28, 2014·27 cites·18 claims
- 0995US7491719B2Enantiomerically pure beta agonists, process for the manufacture thereof, and use thereof as medicamentsBOEHRINGER INGELHEIM INT·Filed 2006·Granted Feb 17, 2009·13 cites·27 claims
- 1095US6608055B2Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical compositionBOEHRINGER INGELHEIM PHARMA·Filed 2002·Granted Aug 19, 2003·44 cites·18 claims
- 1194US10301313B2PolymorphsBOEHRINGER INGELHEIM INT·Filed 2017·Granted May 28, 2019·13 cites·4 claims
- 1294US9266888B2PolymorphsSIEGER PETER·Filed 2014·Granted Feb 23, 2016·28 cites·12 claims
- 1394US7728134B2Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicamentBOEHRINGER INGELHEIM INT·Filed 2005·Granted Jun 1, 2010·30 cites·11 claims
- 1493US9815837B2PolymorphsBOEHRINGER INGELHEIM INT·Filed 2016·Granted Nov 14, 2017·12 cites·3 claims
- 1593US9493462B2PolymorphsBOEHRINGER INGELHEIM INT·Filed 2016·Granted Nov 15, 2016·12 cites·10 claims
- 1693US7932273B23-[(2-{[4-(hexyloxycarbonylaminoiminomethyl) phenylamino]methyl}-1-methyl-1H-benzimidazol-5-carbonyl)pyridin-2-ylamino]propionic acid ethylester methansulfonate and its use as a medicamentBOEHRINGER INGELHEIM INT·Filed 2008·Granted Apr 26, 2011·23 cites·2 claims
- 1791US7119093B23-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical compositionBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Oct 10, 2006·41 cites·7 claims
- 1890US8034816B2Hydrates and polymorphs of 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicamentBOEHRINGER INGELHEIM INT·Filed 2009·Granted Oct 11, 2011·11 cites·14 claims
- 1989US11084819B2PolymorphsBOEHRINGER INGELHEIM INT·Filed 2019·Granted Aug 10, 2021·2 cites·35 claims
- 2089US8329695B2Crystalline form of the free base N-[trans-4-[4-(cyclopropylmethyl)-1-piperazinyl]cyclohexyl]-4-[[(7r)-7-ethyl-5,6,7,8-tetrahydro-5-methyl-8-(1-methylethyl)-6-oxo-2-pteridinyl]amino]-3-methoxy-benzamideLINZ GUENTER·Filed 2008·Granted Dec 11, 2012·8 cites·7 claims
- 2188US8202867B2Methods of using hydrates and polymorphs of 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamideLINZ GUENTER·Filed 2009·Granted Jun 19, 2012·9 cites·13 claims
- 2288US8188086B2Specific salt, anhydrous and crystalline form of a dihydropteridione derivativeLINZ GUENTER·Filed 2008·Granted May 29, 2012·9 cites·5 claims
- 2385US11447474B2Solid forms of a GlyT1 inhibitorBOEHRINGER INGELHEIM INT·Filed 2020·Granted Sep 20, 2022·2 cites·4 claims
- 2485US8426586B2Process for preparing amino crotonyl compoundsSOYKA RAINER·Filed 2006·Granted Apr 23, 2013·14 cites·11 claims
- 2583US8034809B2Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicamentsBOEHRINGER INGELHEIM INT·Filed 2008·Granted Oct 11, 2011·2 cites·40 claims
- 2679US7709474B2Enantiomerically pure beta agonists, manufacturing and use thereofBOEHRINGER INGELHEIM INT·Filed 2007·Granted May 4, 2010·3 cites·16 claims
- 2778US11919903B2PolymorphsBOEHRINGER INGELHEIM INT·Filed 2021·Granted Mar 5, 2024·0 cites·3 claims
- 2877US7534789B2Enantiomeric pure β agonists, manufacturing and use as a medicament thereofBOEHRINGER INGELHEIM INT·Filed 2007·Granted May 19, 2009·2 cites·18 claims
- 2977US6730678B2Benzoylguanidine salt and hydrates thereofBOEHRINGER INGELHEIM PHARMA·Filed 2002·Granted May 4, 2004·5 cites·6 claims
- 3071US7968717B2Crystalline anhydrate with anticholinergic efficacyBOEHRINGER INGELHEIN INTERNAT GMBH·Filed 2004·Granted Jun 28, 2011·6 cites·10 claims
- 3169US6869948B1Meloxicam for oral administrationBOEHRINGER INGELHEIM PHARMA·Filed 1999·Granted Mar 22, 2005·36 cites·18 claims
- 3269US2019233423A1PolymorphsBOEHRINGER INGELHEIM INT·Filed 2019·Application pending·0 cites
- 3367US2022332710A1Solid forms of a glyt1 inhibitorBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 3464US8853225B29-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazoline-6-yloxy]-1,4-diaza-spiro[5.5] undecane-5-one dimaleate, use thereof as a medicament and method for the production thereofPFRENGLE WALDERMAR·Filed 2012·Granted Oct 7, 2014·2 cites·4 claims
- 3563US2007135446A1Benzoylguanidlne salt and hydrates thereofBOEHRINGER INGELHEIM PHARMA·Filed 2007·Application pending·0 cites
- 3663US2018221359A1Administration of ethyl 3-[(2-{[4-(hexyloxycarbonyl-aminoiminomethyl)phenyl-amino]methyl}-1-methyl-1h-benzimidazol-5-carbonyl)pyridin-2-ylamino]propionateBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 3762US2007259900A1PolymorphsSIEGER PETER·Filed 2007·Application pending·0 cites
- 3861US7939658B2Enantiomeric pure beta agonists, manufacturing and use as a medicaments thereofBOEHRINGER INGELHEIM INT·Filed 2009·Granted May 10, 2011·0 cites·7 claims
- 3961US2006217396A1Benzoylguanidine salt and hydrates thereofBOEHRINGER INGELHEIM PHARMA·Filed 2006·Application pending·0 cites
- 4061US2007031347A1Powdered Medicaments Containing A Tiotropium Salt and Salmeterol XinafoateBOEHRINGER INGELHEIM PHARMA·Filed 2006·Application pending·0 cites
- 4161US2012296091A1PolymorphsSIEGER PETER·Filed 2012·Application pending·0 cites
- 4259US8664222B2Specific salt, anhydrous and crystalline form of a dihydropteridione derivativeLINZ GUENTER·Filed 2012·Granted Mar 4, 2014·0 cites·2 claims
- 4359US2009042948A1Physiologically acceptable salts of 3--1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl esterBOEHRINGER INGELHEIM INT·Filed 2008·Application pending·0 cites
- 4458US8906931B19-[4-(3-chloro-2-fluoro-phenylamino-7-methoxy-quinazoline-6-yloxy]-1,4-diaza-spiro[5.5]undecane-5-one dimaleate, use thereof as a medicament and method for the production thereofPFRENGLE WALDEMAR·Filed 2014·Granted Dec 9, 2014·0 cites·2 claims
- 4558US7294721B2(R)-2-(4-amidinophenylaminomethyl)-1-methyl-5-[1-(carboxymethylamino)-1(pyrrolidinocarbonyl)-ethyl]-benzimidazole, the monohydrochloride thereof, preparation thereof and the use as pharmaceutical compositionBOEHRINGER INGELHEIM PHARMA·Filed 2006·Granted Nov 13, 2007·0 cites·1 claims
- 4657US2004152720A1Powdered medicaments containing a tiotropium salt and salmeterol xinafoateBOEHRINGER INGELHEIM PHARMA·Filed 2003·Application pending·0 cites
- 4756US2010317848A1Process for the synthesis of derivatives of 3-amino-tetrahydrofuran-3-carboxylic acid and use thereof as medicamentsBOEHRINGER INGELHEIM INT·Filed 2007·Application pending·0 cites
- 4854US2005043320A1Benzoylguanidine salt and hydrates thereofBOEHRINGER INGELHEIM PHARMA·Filed 2004·Application pending·0 cites
- 4953US2020085807A1Administration of ethyl 3-[(2-{[4-(hexyloxycarbonyl-aminoiminomethyl)phenyl-amino]methyl}-1-methyl-1h-benzimidazol-5-carbonyl)pyridin-2-ylamino]propionateBOEHRINGER INGELHEIM INT·Filed 2019·Application pending·0 cites
- 5053US2005234104A13-[(2-{[4-(hexyloxycarbonylaminoiminomethyl)phenylamino]methyl}-1-methyl-1H-benzimidazol-5-carbonyl)pyridin-2-ylamino]propionic acid ethylester methansulfonate and its use as medicamentBOEHRINGER INGELHEIM INT·Filed 2004·Application pending·0 cites
Showing the top 50 of 77 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →